Sunday October 26, 2014   
Find us Facebook Follow us on Twitter Watch us on YouTube    
Donate Now
  Search
  
Research Grants

Genetic Marker Clinical Trials
Led by Tracy Batchelor, MD, MPH at Massachusetts General Hospital/ Harvard Medical School

These Phase II trials will evaluate and monitor the genetic status of tumors in patients over time using biomarkers. Biomarkers have the potential to show which genetic changes in tumors make patients more responsive to a specific drug, whether genetic changes occur in the tumor during drug treatment, and how the patient responds to therapy.

Batchelor is a recent addition to VABC’s Medical Advisory Board.


Update, 2011

Three of the four subsites for clinical trials have been opened and are currently enrolling patients in the study.



Click here for a full list of research grants funded by Voices Against Brain Cancer.

 

 
Voices Against Brain Cancer is a not-for-profit public charity recognized by the IRS under 501 (c) (3)